GoodRx Holdings (GDRX) Invested Capital (2019 - 2026)

GoodRx Holdings' Invested Capital history runs 8 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Invested Capital fell 3.12% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (down 3.12% YoY), while the FY2025 annual figure was $1.1 billion, down 9.19% from the prior year.
• Invested Capital came in at $1.1 billion for Q1 2026 at GoodRx Holdings, roughly flat from $1.1 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.6 billion in Q2 2023 to a low of $793.5 million in Q1 2022.
• A 5-year average of $1.2 billion and a median of $1.1 billion in 2025 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital soared 93.23% in 2023 and retreated 22.72% in 2024, its largest moves.
• GoodRx Holdings' Invested Capital stood at $1.5 billion in 2022, then dropped by 3.75% to $1.4 billion in 2023, then slipped by 14.25% to $1.2 billion in 2024, then slipped by 9.19% to $1.1 billion in 2025, then rose by 0.44% to $1.1 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison